CoChat

Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis

Open access
Supnet, Charlene, Bezprozvanny, Ilya · 2011 · Cell Calcium
Cited by 95

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Alzheimer disease (AD) is the most common neurodegenerative disorder worldwide and is at present, incurable. The accumulation of toxic amyloid-beta (Aβ) peptide aggregates in AD brain are thought to trigger the extensive synaptic loss and neurodegeneration linked to cognitive decline, an idea that underlies the amyloid hypothesis of AD etiology in both the familal (FAD) and sporadic forms of the disease. Genetic mutations causing FAD also result in the dysregulation of neuronal calcium (Ca2+) handling and may contribute to AD pathogenesis, an idea termed the calcium hypothesis of AD. Mutations in presenilin proteins account for majority of FAD cases. Presenilins function as catalytic subunit of γ-secretase involved in generation of Aβ peptide Recently, we discovered that presenilns function as low-conductance, passive ER Ca2+ leak channels, independent of γ-secretase activity. We further discovered that many FAD mutations in presenilins results in loss of ER Ca2+ leak function activity and Ca2+ overload in the ER. These results provided potential explanation for abnormal Ca2+ signaling observed in FAD cells with mutations in presenilns. The implications of these findings for understanding AD pathogenesis are discussed in this article.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ceca.2011.05.013

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 79

  1. Brookmeyer, 2007, Forecasting the global burden of Alzheimer's disease, Alzheimers Dement., 3, 186, 10.1016/j.jalz.2007.04.381 · DOI · Paper page
  2. Wenk, 2003, Neuropathologic changes in Alzheimer's disease, J. Clin. Psychiatry, 64, 7
  3. Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  4. Bergmans, 2010, gamma-secretases: from cell biology to therapeutic strategies, Lancet Neurol., 9, 215, 10.1016/S1474-4422(09)70332-1 · DOI · Paper page
  5. Cruts, 2008, Loss of progranulin function in frontotemporal lobar degeneration, Trends Genet., 24, 186, 10.1016/j.tig.2008.01.004 · DOI
  6. Cruts, 1998, Presenilin mutations in Alzheimer's disease, Hum. Mutat., 11, 183, 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J · DOI · Paper page
  7. Brown, 2000, Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell, 100, 391, 10.1016/S0092-8674(00)80675-3 · DOI · Paper page
  8. Urban, 2002, Conservation of intramembrane proteolytic activity and substrate specificity in prokaryotic and eukaryotic rhomboids, Curr. Biol., 12, 1507, 10.1016/S0960-9822(02)01092-8 · DOI
  9. Hass, 2009, Presenilin: RIP and beyond, Semin. Cell Dev. Biol., 20, 201, 10.1016/j.semcdb.2008.11.014 · DOI · Paper page
  10. Laudon, 2005, A nine-transmembrane domain topology for presenilin 1, J. Biol. Chem., 280, 35352, 10.1074/jbc.M507217200 · DOI · Paper page
  11. Spasic, 2006, Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway, J. Biol. Chem., 281, 26569, 10.1074/jbc.M600592200 · DOI · Paper page
  12. De Strooper, 1997, Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins, J. Biol. Chem., 272, 3590, 10.1074/jbc.272.6.3590 · DOI · Paper page
  13. Edbauer, 2003, Reconstitution of gamma-secretase activity, Nat. Cell Biol., 5, 486, 10.1038/ncb960 · DOI · Paper page
  14. Kimberly, 2003, Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2, Proc. Natl. Acad. Sci. U.S.A., 100, 6382, 10.1073/pnas.1037392100 · DOI · Paper page
  15. Lazarov, 2006, Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores, Proc. Natl. Acad. Sci. U.S.A., 103, 6889, 10.1073/pnas.0602321103 · DOI · Paper page
  16. Takasugi, 2003, The role of presenilin cofactors in the gamma-secretase complex, Nature, 422, 438, 10.1038/nature01506 · DOI · Paper page
  17. Thinakaran, 1996, Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo, Neuron, 17, 181, 10.1016/S0896-6273(00)80291-3 · DOI · Paper page
  18. Wolfe, 1999, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity, Nature, 398, 513, 10.1038/19077 · DOI · Paper page
  19. Yu, 1998, The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin, J. Biol. Chem., 273, 16470, 10.1074/jbc.273.26.16470 · DOI · Paper page
  20. Demuro, 2010, Calcium signaling and amyloid toxicity in Alzheimer disease, J. Biol. Chem., 285, 12463, 10.1074/jbc.R109.080895 · DOI · Paper page
  21. Stutzmann, 2007, The pathogenesis of Alzheimers disease is it a lifelong “calciumopathy”?, Neuroscientist, 13, 546, 10.1177/1073858407299730 · DOI · Paper page
  22. Supnet, 2010, The dysregulation of intracellular calcium in Alzheimer disease, Cell Calcium, 47, 183, 10.1016/j.ceca.2009.12.014 · DOI · Paper page
  23. Ito, 1994, Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 91, 534, 10.1073/pnas.91.2.534 · DOI · Paper page
  24. Etcheberrigaray, 1998, Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families, Neurobiol. Dis., 5, 37, 10.1006/nbdi.1998.0176 · DOI · Paper page
  25. Khachaturian, 1989, Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview, Ann. N.Y. Acad. Sci., 568, 1, 10.1111/j.1749-6632.1989.tb12485.x · DOI · Paper page
  26. Supnet, 2010, Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease, J. Alzheimers Dis., 20, S487, 10.3233/JAD-2010-100306 · DOI · Paper page
  27. Chan, 2000, Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons, J. Biol. Chem., 275, 18195, 10.1074/jbc.M000040200 · DOI · Paper page
  28. Lee, 2006, PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release, FASEB J., 20, 151
  29. Smith, 2005, Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease, J. Neurochem., 94, 1711, 10.1111/j.1471-4159.2005.03332.x · DOI · Paper page
  30. Chakroborty, 2009, Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice, J. Neurosci., 29, 9458, 10.1523/JNEUROSCI.2047-09.2009 · DOI · Paper page
  31. Goussakov, 2010, NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice, J. Neurosci., 30, 12128, 10.1523/JNEUROSCI.2474-10.2010 · DOI · Paper page
  32. Stutzmann, 2006, Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice, J. Neurosci., 26, 5180, 10.1523/JNEUROSCI.0739-06.2006 · DOI · Paper page
  33. Leissring, 1999, Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals, J. Biol. Chem., 274, 32535, 10.1074/jbc.274.46.32535 · DOI · Paper page
  34. Akbari, 2004, Presenilin regulates capacitative calcium entry dependently and independently of gamma-secretase activity, Biochem. Biophys. Res. Commun., 322, 1145, 10.1016/j.bbrc.2004.07.136 · DOI
  35. Giacomello, 2005, Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia, Neurobiol. Dis., 18, 638, 10.1016/j.nbd.2004.10.016 · DOI
  36. Herms, 2003, Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein, J. Biol. Chem., 278, 2484, 10.1074/jbc.M206769200 · DOI · Paper page
  37. Leissring, 2000, Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice, J. Cell Biol., 149, 793, 10.1083/jcb.149.4.793 · DOI · Paper page
  38. Yoo, 2000, Presenilin-mediated modulation of capacitative calcium entry, Neuron, 27, 561, 10.1016/S0896-6273(00)00066-0 · DOI · Paper page
  39. Zatti, 2004, The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores, Neurobiol. Dis., 15, 269, 10.1016/j.nbd.2003.11.002 · DOI · Paper page
  40. Zhang, 2010, Role of presenilins in neuronal calcium homeostasis, J. Neurosci., 30, 8566, 10.1523/JNEUROSCI.1554-10.2010 · DOI · Paper page
  41. Cheung, 2010, Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons, Sci. Signal., 3, ra22, 10.1126/scisignal.2000818 · DOI · Paper page
  42. Cheung, 2008, Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP(3) receptor channel gating, Neuron, 58, 871, 10.1016/j.neuron.2008.04.015 · DOI · Paper page
  43. Green, 2008, SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production, J. Cell Biol., 181, 1107, 10.1083/jcb.200706171 · DOI · Paper page
  44. Tu, 2006, Presenilins form ER calcium leak channels, a function disrupted by mutations linked to familial Alzheimer's disease, Cell, 126, 981, 10.1016/j.cell.2006.06.059 · DOI · Paper page
  45. Nelson, 2010, Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes, J. Alzheimers Dis., 21, 781, 10.3233/JAD-2010-100159 · DOI · Paper page
  46. Nelson, 2007, Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1, J. Clin. Invest., 117, 1230, 10.1172/JCI30447 · DOI · Paper page
  47. Sato, 2006, Structure of the catalytic pore of gamma-secretase probed by the accessibility of substituted cysteines, J. Neurosci., 26, 12081, 10.1523/JNEUROSCI.3614-06.2006 · DOI · Paper page
  48. Sato, 2008, The C-terminal PAL motif and transmembrane domain 9 of presenilin 1 are involved in the formation of the catalytic pore of the gamma-secretase, J. Neurosci., 28, 6264, 10.1523/JNEUROSCI.1163-08.2008 · DOI · Paper page
  49. Tolia, 2006, Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the {gamma}-secretase complex, J. Biol. Chem., 281, 27633, 10.1074/jbc.M604997200 · DOI · Paper page
  50. Tolia, 2008, Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase, J. Biol. Chem., 283, 19793, 10.1074/jbc.M802461200 · DOI · Paper page
  51. Akabas, 1994, Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the alpha subunit, Neuron, 13, 919, 10.1016/0896-6273(94)90257-7 · DOI · Paper page
  52. Akabas, 1992, Acetylcholine receptor channel structure probed in cysteine-substitution mutants, Science, 258, 307, 10.1126/science.1384130 · DOI · Paper page
  53. Sobhanifar, 2010, Structural investigation of the C-terminal catalytic fragment of presenilin 1, Proc. Natl. Acad. Sci. U.S.A., 107, 9644, 10.1073/pnas.1000778107 · DOI
  54. Nelson, 2011, Mutagenesis mapping of presenilin 1 calcium leak conductance pore, J. Biol. Chem., 10.1074/jbc.M111.243063 · DOI · Paper page
  55. Herl, 2006, Detection of presenilin-1 homodimer formation in intact cells using fluorescent lifetime imaging microscopy, Biochem. Biophys. Res. Commun., 340, 668, 10.1016/j.bbrc.2005.12.063 · DOI
  56. Cervantes, 2001, Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease, FEBS Lett., 505, 81, 10.1016/S0014-5793(01)02785-5 · DOI
  57. Cervantes, 2004, Functional implications of the presenilin dimerization: reconstitution of gamma-secretase activity by assembly of a catalytic site at the dimer interface of two catalytically inactive presenilins, J. Biol. Chem., 279, 36519, 10.1074/jbc.M404832200 · DOI · Paper page
  58. Hebert, 2003, Dimerization of presenilin-1 in vivo: suggestion of novel regulatory mechanisms leading to higher order complexes, Biochem. Biophys. Res. Commun., 301, 119, 10.1016/S0006-291X(02)02984-4 · DOI
  59. Takagi, 2010, Participation of transmembrane domain 1 of presenilin 1 in the catalytic pore structure of the {gamma}-secretase, J. Neurosci., 30, 15943, 10.1523/JNEUROSCI.3318-10.2010 · DOI · Paper page
  60. Oh, 2006, Protease digestion indicates that endogenous presenilin 1 is present in at least two physical forms, Biochem. Biophys. Res. Commun., 346, 330, 10.1016/j.bbrc.2006.05.127 · doi:10.1016/j.bbrc.2006.05.127
  61. Placanica, 2010, Characterization of an atypical gamma-secretase complex from hematopoietic origin, Biochemistry, 49, 2796, 10.1021/bi901388t · DOI
  62. Larner, 2006, Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene, J. Neurol., 253, 139, 10.1007/s00415-005-0019-5 · DOI · Paper page
  63. Shepherd, 2009, Variations in the neuropathology of familial Alzheimer's disease, Acta Neuropathol., 118, 37, 10.1007/s00401-009-0521-4 · DOI
  64. Houlden, 2000, Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations, Ann. Neurol., 48, 806, 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F · DOI · Paper page
  65. Kwok, 1997, Two novel (M233 T and R278 T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype, Neuroreport, 8, 1537, 10.1097/00001756-199704140-00043 · DOI · Paper page
  66. Crook, 1998, A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1, Nat. Med., 4, 452, 10.1038/nm0498-452 · DOI · Paper page
  67. Verkkoniemi, 2001, Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype, J. Neuropathol. Exp. Neurol., 60, 483, 10.1093/jnen/60.5.483 · DOI · Paper page
  68. Karlstrom, 2008, Variable phenotype of Alzheimer's disease with spastic paraparesis, J. Neurochem., 104, 573, 10.1111/j.1471-4159.2007.05038.x · DOI · Paper page
  69. Tabira, 2002, Alzheimer's disease with spastic paresis and cotton wool type plaques, J. Neurosci. Res., 70, 367, 10.1002/jnr.10392 · DOI · Paper page
  70. Ataka, 2004, A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis, Arch. Neurol., 61, 1773, 10.1001/archneur.61.11.1773 · DOI · Paper page
  71. Halliday, 2005, Pick bodies in a family with presenilin-1 Alzheimer's disease, Ann. Neurol., 57, 139, 10.1002/ana.20366 · DOI
  72. Le, 2001, Cotton wool plaques in non-familial late-onset Alzheimer disease, J. Neuropathol. Exp. Neurol., 60, 1051, 10.1093/jnen/60.11.1051 · DOI
  73. Brooks, 2003, Alzheimer's disease with spastic paraparesis and ‘cotton wool’ plaques: two pedigrees with PS-1 exon 9 deletions, Brain, 126, 783, 10.1093/brain/awg084 · DOI · Paper page
  74. Jacquemont, 2002, Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease, J. Med. Genet., 39, E2, 10.1136/jmg.39.2.e2 · DOI
  75. Takao, 2002, A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum, Acta Neuropathol., 104, 155, 10.1007/s00401-002-0536-6 · DOI
  76. Foster, 2007, Calcium homeostasis and modulation of synaptic plasticity in the aged brain, Aging Cell, 6, 319, 10.1111/j.1474-9726.2007.00283.x · DOI · Paper page
  77. Gant, 2006, Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2+-induced Ca2+ release, J. Neurosci., 26, 3482, 10.1523/JNEUROSCI.4171-05.2006 · DOI · Paper page
  78. Toescu, 2007, The importance of being subtle: small changes in calcium homeostasis control cognitive decline in normal aging, Aging Cell, 6, 267, 10.1111/j.1474-9726.2007.00296.x · DOI · Paper page
  79. Bezprozvanny, 2009, Calcium signaling and neurodegenerative diseases, Trends Mol. Med., 15, 89, 10.1016/j.molmed.2009.01.001 · DOI · Paper page

Cited by

See all 95

Metadata

Authors
Supnet, C., & Bezprozvanny, I.
Venue
Cell Calcium
Publisher
Elsevier BV
Published
2011-09
Volume
50
Issue
3
Pages
303-309
ISSN
0143-4160 (ISSN-L)
OpenAlex
W2032419750
Cited by
95
References
12
FWCI
4.62
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. https://app.cochat.ai/papers/10.1016/j.ceca.2011.05.013
The paper
Supnet, C., & Bezprozvanny, I. (2011). Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. Cell Calcium. https://doi.org/10.1016/j.ceca.2011.05.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.